Post Covid-19 Dysautonomia Rehabilitation Randomized Controlled Trial (LoCoDiRe-Dys)
Post-Acute COVID-19 Syndrome, Dysautonomia
About this trial
This is an interventional supportive care trial for Post-Acute COVID-19 Syndrome focused on measuring Long Covid, Post Covid-19 condition, Rehabilitation
Eligibility Criteria
Inclusion Criteria: Adults 18-65 years of age WHO definition of post covid-19 condition Confirmed dysautonomia diagnosis through Ewing Battery Able to attend 2 times/ week for 8 weeks Able to provide informed consent Exclusion Criteria: Absolute or relative contra-indications to exercise due to cardiac pathology Serious mental/ cognitive impairment that will not allow systematic participation Unable to regularly reach the center Pregnancy CFS/ME fulfilling the Canadian Consensus Criteria Secondary health conditions that would explain symptoms, intervene in dysautonomia diagnosis or would impede participation in the exercise protocol (i.e. , untreated hypothyroidism and Diabetes Melitus, major psychiatric disorders, COPD, PICS, Pulmonary Fibrosis, chronic respiratory or heart failure, not ambulatory, suffering from dementia, chronically paralyzed, with paraplegia, with multiple injuries or other serious orthopedic problems that caused disability, patients suffering from very serious underlying diseases such as end-stage cancer, and those with neurological diseases causing disability)
Sites / Locations
- First Department of Critical Care Medicine and Pulmonary Services, Evangelismos Hospital, National and Kapodistrian University of AthensRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
LoCoDiRe-Dys
Standard of Care
Respiratory physiotherapy, personalized aerobic and strength training in parallel with standard of care
Standard of care including behavioural and medical advice